Suzie Marriott and Helen Cole have been recognised in the inVESTigate (VEST) trial newsletter. The VEST trial is an observational study of patients receiving vedolizumab for Inflammatory Bowel Disease. They have been recognised for exceeding their target and for being the top recruiting site outside of the lead centre.Gastro Research Team